Grapefruit Usa Inc Quick Ratio (GPFT) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Grapefruit Usa Inc   (GPFT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Grapefruit Usa Inc 's Quick Ratio

GPFT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 0 a new company low.

Within Medical Laboratories industry 52 other companies have achieved higher Quick Ratio than Grapefruit Usa Inc in third quarter 2022. While Quick Ratio total ranking has improved so far during the Q3 2022 to 5044, from total ranking in the second quarter 2022 at 5806.

Explain Quick Ratio?
How much Cash & cash equivalents GPFT´s has?
What are GPFT´s Current Liabilities?




GPFT Quick Ratio (Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
(Dec 31 2021)
Q4
(Sep 30 2021)
Q3
Y / Y Current Liabilities Change 65.34 % 63.36 % 17.09 % 75.9 % -64.87 %
Y / Y Cash & cash equivalent Change -36.8 % -97.32 % -98.83 % -96.97 % -77.5 %
Quick Ratio MRQ 0 0 0 0 0.01
GPFT's Total Ranking # 5044 # 5806 # 6133 # 6103 # 5923
Seq. Current Liabilities Change 8.68 % -10.07 % 5.11 % 60.96 % 7.37 %
Seq. Cash & cash equivalent Change 368.38 % -2.29 % -43.34 % -75.63 % -80.17 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Medical Laboratories Industry # 53
Healthcare Sector # 1098
Overall Market # 5044


Quick Ratio Statistics
High Average Low
0.54 0.04 0
(Sep 30 2014)   (Mar 31 2016)




Financial Statements
Grapefruit Usa Inc 's Current Liabilities $ 8 Millions Visit GPFT's Balance sheet
Grapefruit Usa Inc 's Cash & cash equivalent $ 0 Millions Visit GPFT's Balance sheet
Source of GPFT's Sales Visit GPFT's Sales by Geography


Cumulative Grapefruit Usa Inc 's Quick Ratio

GPFT's Quick Ratio for the trailling 12 Months

GPFT Quick Ratio

(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
(Dec 31 2021)
12 Months
(Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 50.92 % -5.13 % -20.17 % -23.98 % -36.07 %
Y / Y Cash & cash equivalent TTM Growth -95.56 % -94.83 % -76.21 % -3.72 % 44.58 %
Quick Ratio TTM 0 0 0.01 0.03 0.05
Total Ranking TTM # 4755 # 4762 # 4876 # 5067 # 4752
Seq. Current Liabilities TTM Growth 11.22 % 11.28 % 4.95 % 16.18 % -30.09 %
Seq. Cash & cash equivalent TTM Growth -24.27 % -76.39 % -64.52 % -30.09 % -11.74 %


On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q3 2022 to $7.91 millions, cumulative Quick Ratio